
|Poll|August 22, 2019
Poll: Is DRE still a relevant tool in the management of prostate cancer?
Do you feel that DRE is still a relevant tool in the management of prostate cancer? Take our latest poll and let us know.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
ARASEC: Clinical Implications and the Role of Multidisciplinary Care
2
FDA grants tentative approval to generic enzalutamide tablets
3
2026 AUA/SUO Advanced Prostate Cancer Guideline: Key updates and clinical FAQs
4
Fred Saad, MD, highlights PSA end points from the phase 3 PSMAddition trial
5













